Bausch Health to Appeal XIFAXAN® Patent Decision to U. S. Court of Appeals for the Federal Circuit – PR Newswire
LAVAL, Quebec , Aug. 10, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the particular company's July 28,…